In a recent study, we reported that DBZ (danshensu bingpian zhi), a putative PPARγ agonist, simultaneously prevented HFD-induced obesity-related metabolic syndrome and gut dysbiosis. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.